Guía de práctica clínica para el tratamiento farmacológico y psicológico de los pacientes adultos con un trastorno de ansiedad y un diagnóstico comórbido de trastorno por uso de sustancias

  1. Pilar A. Sáiz
  2. Gerardo Flórez
  3. Manuel Arrojo
  4. Miquel Bernardo
  5. Ana González Pinto
  6. José Manuel Goikolea
  7. Iñaki Zorrilla
  8. Ruth Cunill
  9. Xavier Castells
  10. Elisardo Becoña
  11. Ana López
  12. Marta Torrens
  13. Francina Fonseca
  14. Judit Tirado-Muñoz
  15. Belén Arranz
  16. Marina Garriga
  17. Luis San
Revista:
Adicciones: Revista de socidrogalcohol

ISSN: 0214-4840

Any de publicació: 2022

Volum: 34

Número: 2

Pàgines: 157-167

Tipus: Article

DIALNET GOOGLE SCHOLAR lock_openAccés obert editor

Altres publicacions en: Adicciones: Revista de socidrogalcohol

Resum

This review synthesizes the pharmacological and psychosocial interventions that have been conducted in comorbid anxiety disorders and SUDs while also providing clinical recommendations about which intervention elements are helpful for addressing substance use versus anxiety symptoms in patients with these co-occurring conditions. The best evidence from randomized controlled trials was used to evaluate treatment options. The strength of recommendations was described using the GRADE approach. Clinical trials are only available for posttraumatic stress disorder (PTSD) and for social anxiety. Concerning the comorbid substance use, all the studies have included patients with alcohol use, none of them have dealt with cocaine, cannabis or nicotine use. Although some treatments have shown benefit for anxiety symptoms without benefits for alcohol or other substance use, only limited pharmacological approaches have been assayed (sertraline, desipramine, paroxetine, buspirone, naltrexone and disulfiram). Our results suggest that 1) we can (weakly) recommend the use of desipramine over paroxetine to alleviate symptoms of anxiety in patients with a PTSD and alcohol use; 2) In these patients, the use of naltrexone to reduce symptoms of anxiety is also recommended (weak strength); and 3) SSRI antidepressants vs placebo can be recommended to reduce alcohol use (weak recommendation). Our review highlights the need for more research in this area and for larger, multisite studies with generalizable samples to provide more definite guidance for clinical practice.

Referències bibliogràfiques

  • American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington, DC: American Psychiatric Association. doi:10.1176/appi.books.9780890425596.
  • Back, S. E., Brady, K. T., Sonne, S. C. y Verduin, M. L. (2006). Symptom improvement in co-occurring PTSD and alcohol dependence. The Journal of Nervous and Mental Disease, 194, 690–696. doi:10.1097/01.nmd.0000235794.12794.8a.
  • Book, S. W., Thomas, S. E., Randall, P. K. y Randall, C. L. (2008). Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder. Journal of Anxiety Disorders, 22, 310–318. doi:10.1016/j.janxdis.2007.03.001.
  • Brady, K. T., Killeen, T. K., Brewerton, T. y Lucerini, S. (2000). Comorbidity of psychiatric disorders and posttraumatic stress disorder. The Journal of Clinical Psychiatry, 61 (Suppl 7), 22–32.
  • Brady, K. T., Sonne, S. C. y Roberts, J. M. (1995). Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. Journal of Clinical Psychiatry, 56, 502–505.
  • Clark, H. W., Masson, C. L., Delucchi, K. L., Hall, S. M. y Sees, K. L. (2001). Violent traumatic events and drug abuse severity. Journal of Substance Abuse Treatment, 20, 121–127. doi:10.1016/s0740-5472(00)00156-2.
  • Compton, W. M., Thomas, Y. F., Stinson, F. S. y Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64, 830–842. doi:10.1001/archpsyc.64.5.566.
  • Driessen, M., Schulte, S., Luedecke, C., Schaefer, I., Sutmann, F., Ohlmeier, M.,… Havemann-Reinecke, U. (2008). Trauma and PTSD in patients with alcohol, drug, or dual dependence: A multi-center study. Alcoholism, Clinical and Experimental Research, 32, 481–488. doi:10.1111/j.1530-0277.2007.00591.x.
  • Gimeno, C., Dorado, M. L., Roncero, C., Szerman, N., Vega, P., Balanzá-Martínez, V. y Alvarez, F. J. (2017). Treatment of comorbid alcohol dependence and anxiety disorder: Review of the scientific evidence and recommendations for treatment. Frontiers in Psychiatry, 8, 1–14. doi:10.3389/fpsyt.2017.00173.
  • Gopalakrishna, G., Langendam, M. W., Scholten, R. J., Bossuyt, P. M. y Leeflang, M. M. (2013). Guidelines for guideline developers: A systematic review of grading systems for medical tests. Implementation Science, 8, 78. doi:10.1186/1748-5908-8-78.
  • Guyatt, G. H., Oxman, A. D., Kunz, R., Falck-Ytter, Y., Vist, G. E., Liberati, A. y Schünemann, H. J. (2008). Going from evidence to recommendations. BMJ, 336, 1049–1051. doi:10.1136/bmj.39493.646875.AE.
  • Guyatt, G. H., Oxman, A. D., Sultan, S., Glasziou, P., Akl, E. A., Alonso-Coello, P.,… Schünemann, H. J. (2011). GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology, 64, 1311–1316. doi:10.1016/j.jclinepi.2011.06.004.
  • Hesse, M. (2009). Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry, 9, 6. doi:10.1186/1471-244X-9-6.
  • Hunt, G. E., Siegfried, N., Morley, K., Sitharthan, T. y Cleary, M. (2013). Psychosocial interventions for people with both severe mental illness and substance misuse. The Cochrane Database of Systematic Reviews, 10, CD001088. doi:10.1002/14651858.CD001088.pub3.
  • Ipser, J. C., Wilson, D., Akindipe, T. O., Sager, C. y Stein, D. J. (2015). Pharmacotherapy for anxiety and comorbid alcohol use disorders. Cochrane Database Syst Rev, 1, Cd007505. doi:10.1002/14651858.CD007505.pub2.
  • Iqbal, M. N., Levin, C. J. y Levin, F. R. (2019). Treatment for substance use disorder with co-occurring mental illness. Focus, 17, 88–97. doi:10.1176/appi.focus.20180042.
  • Kranzler, H. R., Burleson, J. A., Del Boca, F. K., Babor, T. F., Korner, P., Brown, J. y Bohn, M. J. (1994). Buspirone treatment of anxious alcoholics. A placebo-controlled trial. Archives of General Psychiatry, 51, 720–731.
  • Labbate, L. A., Sonne, S. C., Randal, C. L., Anton, R. F. y Brady, K. T. (2004). Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders? Comprehensive Psychiatry, 45, 304–310. doi:10.1016/j.comppsych.2004.03.015.
  • Lopez-Quintero, C., Perez de los Cobos, J., Hasin, D. S., Okuda, M., Wang, S., Grant, B. F. y Blanco, C. (2011). Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug and Alcohol Dependence, 115, 120–130. doi:10.1016/j.drugalcdep.2010.11.004.
  • María-Ríos, C. E. y Morrow, J. D. (2020). Mechanisms of shared vulnerability to post-traumatic stress disorder and substance use disorders. Frontiers in Behavioral Neuroscience, 14, 1–21. doi:10.3389/fnbeh.2020.00006.
  • McCauley, J. L., Killeen, T., Gros, D. F., Brady, K. T. y Back, S. E. (2012). Posttraumatic stress disorder and co-occurring substance use disorders: Advances in assessment and treatment. Clinical Psychology, 19. doi:10.1111/cpsp.12006.
  • Mustafa, R. A., Santesso, N., Brozek, J., Akl, E. A., Walter, S. D., Norman, G.,… Schünemann, H. J. (2013). The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. Journal of Clinical Epidemiology, 66, 736–742. doi:10.1016/j.jclinepi.2013.02.004.
  • Oxman, A. D., Schünemann, H. J. y Fretheim, A. (2006). Improving the use of research evidence in guideline development: 2. Priority setting. Health Research Policy and Systems, 4, 14. doi:10.1186/1478-4505-4-14.
  • Petrakis, I. L., Poling, J., Levinson, C., Nich, C., Carroll, K., Ralevski, E. y Rounsaville, B. (2006). Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder. Biological Psychiatry, 60, 777–783. doi:10.1016/j.biopsych.2006.03.074.
  • Petrakis, I. L., Ralevski, E., Desai, N., Trevisan, L., Gueorguieva, R., Rounsaville, B. y Krystal, J. H. (2012). Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology, 37, 996–1004. doi:10.1038/npp.2011.283.
  • Randall, C. L., Johnson, M. R., Thevos, A. K., Sonne, S. C., Thomas, S. E., Willard, S. L.,… Davidson, J. R. (2001). Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depression and Anxiety, 14, 255–262. doi:10.1002/da.1077.
  • Sáiz, P. A., Jimenez, L., Díaz, E. M., García-Portilla, M. P., Marina, P., Al-Halabí, S.,… Ruiz, P. (2014). Patología dual en trastornos de ansiedad: Recomendaciones en el tratamiento farmacológico. Adicciones, 26, 254–274. doi:10.20882/adicciones.7.
  • San, L. y Arranz, B. (2016). Clinical guideline for the treatment of dual pathology in the adult population. Adicciones, 28, 3-5. doi:10.20882/adicciones.784.
  • Smith, J. P. y Book, S. W. (2008). Anxiety and substance use disorders: A review prevalence of comorbid anxiety and substance use disorders. The Psychiatric Times, 25, 19–23.
  • Thomas, S. E., Randall, P. K., Book, S. W. y Randall, C. L. (2008). A complex relationship between co-occurring social anxiety and alcohol use disorders: What effect does treating social anxiety have on drinking? Alcoholism, Clinical and Experimental Research, 32, 77–84. doi:10.1111/j.1530-0277.2007.00546.x.
  • Torchalla, I., Nosen, L., Rostam, H. y Allen, P. (2012). Integrated treatment programs for individuals with concurrent substance use disorders and trauma experiences: A systematic review and meta-analysis. Journal of Substance Abuse Treatment, 42, 65–77. doi:10.1016/j.jsat.2011.09.001.
  • Vorspan, F., Mehtelli, W., Dupuy, G., Bloch, V. y Lépine, J. P. (2015). Anxiety and substance use disorders: Co-occurrence and clinical issues. Current Psychiatry Reports, 17. doi:10.1007/s11920-014-0544-y.
Fuente de los datos: Dialnet